Leitrim Rose, Catherine Cullen, is hosting a pilates and wellness morning to fundraise ahead of the Dublin City Marathon this ...

This post is the first in a five-part series summarizing APDA’s recent “Ask the Expert” event on Smart Patients. During the ...

Tiziana Life Sciences Ltd (NASDAQ:TLSA) has asked the US Food and Drug Administration to grant orphan drug designation to its intranasal foralumab for multiple system atrophy (MSA), a rare ...

A gene signature in the blood may reveal Parkinson’s decades before the first tremor, a new Swedish and Norwegian study ...

FDA accepts filing for fenebrutinib, an investigational BTK inhibitor, for relapsing (RMS) and primary progressive (PPMS) multiple sclerosis.

Fenebrutinib cut relapses by 51% and 58% vs teriflunomide in Phase III RMS trials (FENhance 1 & 2) while showing a consistent, positive trend in delaying disability 1; Fenebrutini ...

Newronika received FDA approval of an Investigational Device Exemption, allowing the company to initiate the ADVENT pivotal ...

Brain biomarkers were long hard to pin down. See how new Parkinson's and Alzheimer's biomarkers are changing that.

Fenebrutinib cut relapses by 51% and 58% vs teriflunomide in Phase III RMS trials (FENhance 1 & 2) while showing a consistent, positive trend in delaying disability 1; Fenebrutini ...

Poster Title: Long-Term Open-Label Data on the GCase Modulator GT-02287 ( Rexaceract) in People with Parkinson’s Disease Location : Hall D, 3 rd Floor, E-Poster Station 12 The International Parkinson ...